Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.
ADMA Biologics, Inc. (ADMA) has a market cap of $2.50B with year-over-year revenue growth of +65.2%. Net margin stands at 46.4%. The stock trades at a P/E ratio of 12.6.
Compared to other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, ADMA posted revenue growth of +65.2% and trades at a P/E of 12.6.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.